News Regeneron ends development of RSV antibody Regeneron dumps suptavumab after phase 3 trial failure.
News Mundipharma buys rights to CellAct cancer drug Drug will be progressed through phase 3 trials in biliary tract cancer.
News Ionis to file rare disease drug after GSK declines option Firm turns down options for inotersen and IONIS-FB-LRX.
News UK researchers trial new cancer immunotherapy The charity Cancer Research UK has joined with Biotecnol to begin early-stage clinical trials of a new kind of cancer immunotherapy in solid tumours, including lung cancers.
Views & Analysis Challenging antimicrobial drug resistance with calorimetry Tackling antimicrobial drug resistance with calorimetry.
News GW prepares for 2018 US launch of epilepsy drug But Zynerba's cannabis epilepsy drug fails in phase 2.
R&D Sponsored Turning recruitment potential into enrolment reality In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Karen Townsend, senior director of medical affairs discusses SEELs
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
